CARL ZEISS MEDITEC AG overview

EQS-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Half Year Results/Quarter Results Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25 15-Apr-2025 / 08:57 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25 Jena, April 15, 2025 In the...

ZEISS receives FDA clearance for INTRABEAM 700 PR Newswire JENA, Germany, April 9, 2025 With its new treatment platform for intraoperative radiotherapy, ZEISS is actively shaping the medical innovation of neuro tumor therapy. JENA, Germany , April 9, 2025 /PRNewswire/ -- As a leading provider of medical solutions in the field of neurosurgery, ZEISS Medical Technology is also dedicated to shaping modern oncology. The company recently received 510(k) clearance from the US Food and Drug...

EQS-News: Carl Zeiss Meditec AG / Key word(s): Regulatory Approval ZEISS VISUMAX 800 with SMILE pro software receives approval in China 27.02.2025 / 10:38 CET/CEST The issuer is solely responsible for the content of this announcement. ZEISS VISUMAX 800 with SMILE pro software receives approval in China Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment, greater flexibility, and significant workflow enhancements. JENA,(Germany), SHANGHAI, (China), | 27...

EQS-News: Carl Zeiss Meditec AG / Key word(s): Quarterly / Interim Statement/Quarter Results Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25 12.02.2025 / 06:58 CET/CEST The issuer is solely responsible for the content of this announcement. Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25 Significant recovery in order entry and order backlog JENA, 12 February 2025 Carl Zeiss Meditec generated revenue of €490.5m in the first...